- Group Leader, Early Cancer Institute, University of Cambridge
- Wellcome Early Career Award researcher
- Honorary consultant haematologist, Addenbrooke’s Hospital, Cambridge
Biography
Caroline qualified in Medicine from the University of Oxford in 2010, before specialising in haematology in 2014. In 2017, she moved to Cambridge to join Jamie Blundell’s lab in the CRUK Cambridge Centre Early Detection Programme as a CRUK-Clinical Research Fellow. She obtained her PhD in 2022 for her thesis titled The evolutionary dynamics of clonal haematopoiesis and its progression to acute myeloid leukaemia’, for which she was awarded a Milo Keynes PhD thesis prize from the University of Cambridge.
In 2023, Caroline was awarded a Wellcome Early Career Award and was appointed as a Junior Group leader at the Early Cancer Institute. Caroline also works as an Honorary Haematology Consultant at Addenbrooke’s Hospital, where she has been involved in the setup of the Cambridge Clonal Haematopoiesis clinic, a national referral clinic for high-risk clonal haematopoiesis.
The Watson group is focused on using longitudinal state-of-the-art multi-omic approaches to gain a better understanding of the factors that affect progression of ‘pre-leukaemic’ conditions to leukaemia, with the goal of developing therapeutic strategies that may ultimately prevent the development of leukaemia.
Publications list:
Google scholar: https://scholar.google.com/citations?hl=en&user=uYmWZPgAAAAJ